Paradigm BiopharmaceuticalsPAR 
$0.16-4.08%24h
-4.08%24h
Global rank24580
Market cap$46.05M
Change 7d-16.07%
YTD Performance-46.59%
SP500 benchmarkUnderperform
P/E-0.89
P/S1455.83
Revenue$31.63K
Earnings-$35.12M
Dividend yield-
Main Sector
Healthcare
Paradigm Biopharmaceuticals (PAR) Net Assets
PAR Net Assets in 2023: $53.68M
As of 25 Nov 2024, Paradigm Biopharmaceuticals net assets is $53.68M, an increase of 26.86% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Paradigm Biopharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Paradigm Biopharmaceuticals Net Assets History from 2019 to 2024
-
Value:-
PAR Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $53.68M | 26.86% |
| 2022 | $42.31M | -45.94% |
| 2021 | $78.27M | -27.65% |
| 2020 | $108.18M | 30.64% |
| 2019 | $82.81M | - |
View the Top Net Assets Companies
